Clinical Trial Update: Study of the Safety and Efficacy of Ferrlecit® Maintenance Dosing in Pediatric Hemodialysis Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated the safety and efficacy of Ferrlecit maintenance dosing in pediatric patients undergoing hemodialysis for anemia, with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• FERRLECIT (SODIUM FERRIC GLUCONATE COMPLEX)

Snippet

Sponsor: Watson Pharmaceuticals | Conditions: Anemia | Phase 4 | Status: COMPLETED | Results posted: 2009-09-28